NEWS | Research at LSUHS

KSLA - 

LSU Health Shreveport (LSUHS) announced it will soon have a new research space at Mall St. Vincent. The former Sears location is being converted into 181,000 square feet of Class A research space to support expanded research into cancer, cardiovascular disease and other areas.

While life circumstances and mental health play major roles, scientists have long known that suicide risk can run in families and common genes are linked to suicidal behavior. What remains less clear is how those common genes function in the body.

Sadiya Parveen Nesson, PhD, Assistant Professor of Microbiology and Immunology, was awarded a three-year, $766,500 COBRE grant from the Center for Lung Biology and Disease (CLBD) at LSU Baton Rouge.

Gengyi Zou, MD, PhD selected as a recipient of the Gilead Sciences Research Scholars Program Award in Solid Tumors, a highly competitive award that supports outstanding junior faculty conducting innovative cancer research.

Yoshikazu Tsukasaki, PhD was awarded a three-year, $1.1 million R01 transfer grant from the NIH National Institute of Allergy and Infectious Diseases for the remaining three years of his project.

Tousif Sultan, PHD, Assistant Professor of Cellular Biology and Anatomy, was awarded a competitive one-year grant from the AHA to investigate cell-specific pathways driving cardiac inflammation.

LSU Health Shreveport recently completed a year-long federal study, examining the healthcare and public health impacts of the two devastating 2024 hurricanes as part of the National Disaster Medical System (NDMS) Pilot Program, a federal initiative focused on strengthening the nation’s medical readiness during catastrophic events.

Gengyi Zou, MD, PhD, Assistant Professor of Pharmacology, Toxicology and Neuroscience, studies how aggressive gastric tumors evolve and how those changes can be targeted with new treatments

Louisiana State University - LSU’s Flagship has surpassed $600 million in annual research activity, building on last year’s record-setting milestone when the campuses exceeded $500 million for the first time ever. This marks the fifth consecutive year of record-breaking research wins.   

Dr. Mohamed Noureldein, who recently joined LSUHS, explores why some people remain mentally sharp and active well into older age while others experience significant cognitive decline? What happens when the brain can no longer access the energy it needs to function?

LSUHS researchers A. Wayne Orr, PhD, and Arif Yurdagul, PhD, received a $2,869,114 NIH R01 award from the NIH National Heart, Lung, and Blood Institute (NHLBI) to advance research in cardiovascular disease.

Dr. Julie Schwertfeger, Assistant Professor at LSUHS, played a key role in contributing to the research methods, data analysis, and data interpretation for a recent publication in the Journal of Neurotrauma.

LSU Health Shreveport researchers Oren Rom, PhD, RD, and Arif Yurdagul, PhD, received a $2,902,365 award from the NIH National Heart, Lung, And Blood Institute (NHLBI) to advance research in cardiovascular disease.

Dr. Julie Schwertfeger's work at LSUHS focuses on transcranial electric stimulation (TES), which uses very small electrical currents delivered through a cap worn on the head to gently encourage brain cells to become more responsive after an injury.

Clinical trials are part of a careful scientific process to improve health outcomes and assure the safety of those who will receive a particular medication or device after FDA approval. Ultimately, biomedical research, including clinical trials, provides hope that better solutions to disease and suffering are possible and will be found.